Microbix Biosystems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Microbix Biosystems generated cash of $4,347,620, which is more than the previous year. Cash used in financing activities reached the amount of -$1,084,018 last year. Net change in cash is therefore $1,356,852.
Cash Flow
| 2015 | 595.40K | -4.84M | 3.80M |
|---|---|---|---|
| 2016 | 913.30K | -1.64M | 629.05K |
| 2017 | 297.04K | -640.75K | 392.74K |
| 2018 | -537.00K | -1.21M | 1.74M |
| 2019 | 44.36K | -514.8K | 521.64K |
| 2020 | 8.56K | -813.90K | 802.43K |
| 2021 | 2.10M | -622.33K | 8.40M |
| 2022 | 3.46M | -2.02M | 2.06M |
| 2023 | -1.09M | -1.01M | 229.20K |
| 2024 | 4.34M | -1.90M | -1.08M |
MBX.TO Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.60M | 13.48M | 9.98M | 92.66K | 95.57K | 44.35K | 54.46K | 5.41K | 104.18K | 547.35K |
Operating activities | ||||||||||
Net income | 3.52M | -39.48K | 1.78M | 3.23M | -6.22M | 31.91K | -8.62M | -3.78M | 748.40K | 613.98K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.61M | 1.15M | 1.03M | 822.04K | 690.08K | 568.82K | 690.07K | 510.15K | 413.67K | 418.42K |
Stock-based compensation expense | 714.29K | 735.31K | 649.69K | 377.82K | 158.83K | 151.98K | 0 | 485.08K | 334.75K | 580.62K |
| Deferred income tax benefit | 714.29K | 735.31K | 649.69K | 377.82K | 158.83K | 151.98K | 0 | 485.08K | 334.75K | 580.62K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -12.71K | -1.06M | 1.11M | -2.29M | -167.53K | -395.99K | 24.00K | 684.38K | -329.79K | 449.43K |
Inventories | -712.37K | -467.11K | -877.41K | -114.84K | 187.52K | -33.22K | 20.13K | -1.07M | 229.27K | -2.02M |
Accounts payable | 0 | 86.86K | 0 | -115.77K | -45.33K | -208.83K | -1.03M | 878.59K | -589.49K | 0 |
Cash generated by operating activities | 4.34M | -1.09M | 3.46M | 2.10M | 8.56K | 44.36K | -537.00K | 297.04K | 913.30K | 595.40K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.63M | -1.01M | -2.02M | -1.30M | -813.90K | -514.8K | -1.21M | -640.75K | -1.64M | -4.84M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.90M | -1.01M | -2.02M | -622.33K | -813.90K | -514.8K | -1.21M | -640.75K | -1.64M | -4.84M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 3.44M | 6.13M | 2.15M | 0 | 3.13M | 0 | 531.67K | 901.83K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -925.27K | -1.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -522.48K | 1.23M | -1.38M | -546.70K | -690.41K | 521.64K | -1.82M | 392.74K | -402.62K | 1.16M |
Cash used in financing activities | -1.08M | 229.20K | 2.06M | 8.40M | 802.43K | 521.64K | 1.74M | 392.74K | 629.05K | 3.80M |
Net Change In Cash | 1.35M | -1.88M | 3.50M | 9.89M | -2.91K | 51.21K | -10.10K | 49.04K | -98.76K | -443.17K |
Cash at end of period | 12.96M | 11.60M | 13.48M | 9.98M | 92.66K | 95.57K | 44.35K | 54.46K | 5.41K | 104.18K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |